163 related articles for article (PubMed ID: 22014829)
1. Novel antileukemic agents derived from tamibarotene and nitric oxide donors.
Bian H; Feng J; Li M; Xu W
Bioorg Med Chem Lett; 2011 Dec; 21(23):7025-9. PubMed ID: 22014829
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological characterization of tamibarotene analogs as anticancer agents.
Jiang Y; Li X; Wang X; Wang Z; Zhang J; Wu J; Xu W
Chem Biol Drug Des; 2016 Oct; 88(4):542-55. PubMed ID: 27113097
[TBL] [Abstract][Full Text] [Related]
3. Preparation and antitumor activity of a tamibarotene-furoxan derivative.
Wang XJ; Duan Y; Li ZT; Feng JH; Pan XP; Zhang XR; Shi LH; Zhang T
Asian Pac J Cancer Prev; 2014; 15(15):6343-7. PubMed ID: 25124622
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cytotoxic activity of nitric oxide-releasing isosteviol derivatives.
Wang TT; Liu Y; Chen L
Bioorg Med Chem Lett; 2014 May; 24(9):2202-5. PubMed ID: 24685545
[TBL] [Abstract][Full Text] [Related]
5. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
6. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of new retinobenzoic acids.
Khandare RP; Vaze KR; Bhat SV
Chem Biodivers; 2011 May; 8(5):841-9. PubMed ID: 21560232
[TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-delta.
Uruno A; Noguchi N; Matsuda K; Nata K; Yoshikawa T; Chikamatsu Y; Kagechika H; Harigae H; Ito S; Okamoto H; Sugawara A
J Leukoc Biol; 2011 Aug; 90(2):235-47. PubMed ID: 21393419
[TBL] [Abstract][Full Text] [Related]
9. Licofelone-nitric oxide donors as anticancer agents.
Liu W; Zhou J; Liu Y; Liu H; Bensdorf K; Guo C; Gust R
Arch Pharm (Weinheim); 2011 Aug; 344(8):487-93. PubMed ID: 21681808
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives.
Desplat V; Moreau S; Belisle-Fabre S; Thiolat D; Uranga J; Lucas R; de Moor L; Massip S; Jarry C; Mossalayi DM; Sonnet P; Déléris G; Guillon J
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):657-67. PubMed ID: 21250818
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and potent antileukemic activities of 10-benzyl-9(10H)-acridinones.
Gao C; Jiang Y; Tan C; Zu X; Liu H; Cao D
Bioorg Med Chem; 2008 Sep; 16(18):8670-5. PubMed ID: 18713666
[TBL] [Abstract][Full Text] [Related]
12. A112, a tamibarotene dimethylaminoethyl ester, may inhibit human leukemia cell growth more potently than tamibarotene.
Yuan C; Zhang YS; Cheng YN; Xue X; Xu WF; Qu XJ
Leuk Lymphoma; 2012 Feb; 53(2):295-304. PubMed ID: 21846186
[TBL] [Abstract][Full Text] [Related]
13. New nitric oxide donating 1,2,4-triazole/oxime hybrids: synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activities.
Abdel-Aziz M; Abuo-Rahma Gel-D; Beshr EA; Ali TF
Bioorg Med Chem; 2013 Jul; 21(13):3839-49. PubMed ID: 23665142
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological characterization of Disila-AM80 (Disila-tamibarotene) and Disila-AM580, silicon analogues of the RARalpha-selective retinoid agonists AM80 (Tamibarotene) and AM580.
Tacke R; Müller V; Büttner MW; Lippert WP; Bertermann R; Daiss JO; Khanwalkar H; Furst A; Gaudon C; Gronemeyer H
ChemMedChem; 2009 Nov; 4(11):1797-802. PubMed ID: 19790202
[No Abstract] [Full Text] [Related]
15. Synthesis and antileukemic activity of novel 2-(4-(2,4-dimethoxybenzoyl)phenoxy)-1-(4-(3-(piperidin-4-yl)propyl)piperidin-1-yl)ethanone derivatives.
Vinaya K; Kavitha CV; Prasanna DS; Chandrappa S; Ranganatha SR; Raghavan SC; Rangappa KS
Chem Biol Drug Des; 2012 Mar; 79(3):360-7. PubMed ID: 22181584
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents.
Zou ZH; Lan XB; Qian H; Huang WL; Li YM
Bioorg Med Chem Lett; 2011 Oct; 21(19):5934-8. PubMed ID: 21843940
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol.
Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J
Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel furozan-based nitric oxide-releasing derivatives of oridonin as potential anti-tumor agents.
Li D; Wang L; Cai H; Zhang Y; Xu J
Molecules; 2012 Jun; 17(6):7556-68. PubMed ID: 22710829
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and antiproliferative activity of some new azapyranoxanthenone aminoderivatives.
Kolokythas G; Pouli N; Marakos P; Pratsinis H; Kletsas D
Eur J Med Chem; 2006 Jan; 41(1):71-9. PubMed ID: 16300857
[TBL] [Abstract][Full Text] [Related]
20. 1,2,4-Triazole/oxime hybrids as new strategy for nitric oxide donors: Synthesis, anti-inflammatory, ulceroginicity and antiproliferative activities.
Abuo-Rahma Gel-D; Abdel-Aziz M; Beshr EA; Ali TF
Eur J Med Chem; 2014 Jan; 71():185-98. PubMed ID: 24308998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
